Hepatitis B Virus Reactivation in Asian Patients Treated With Rituximab-containing Treatment.
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Adverse reactions
- 25 Oct 2017 Status changed from active, no longer recruiting to completed.
- 14 Jan 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 14 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.